ES527514A0 - Procedimiento para la obtencion de medios antimicoticos en forma de gel - Google Patents

Procedimiento para la obtencion de medios antimicoticos en forma de gel

Info

Publication number
ES527514A0
ES527514A0 ES527514A ES527514A ES527514A0 ES 527514 A0 ES527514 A0 ES 527514A0 ES 527514 A ES527514 A ES 527514A ES 527514 A ES527514 A ES 527514A ES 527514 A0 ES527514 A0 ES 527514A0
Authority
ES
Spain
Prior art keywords
gel
antimycotic
media
procedure
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES527514A
Other languages
English (en)
Other versions
ES8502337A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6178958&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES527514(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES527514A0 publication Critical patent/ES527514A0/es
Publication of ES8502337A1 publication Critical patent/ES8502337A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
ES527514A 1982-11-25 1983-11-24 Procedimiento para la obtencion de medios antimicoticos en forma de gel Expired ES8502337A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823243546 DE3243546A1 (de) 1982-11-25 1982-11-25 Antimykotische mittel in gelform zur behandlung von pilzinfektionen der mundhoehle

Publications (2)

Publication Number Publication Date
ES527514A0 true ES527514A0 (es) 1985-01-01
ES8502337A1 ES8502337A1 (es) 1985-01-01

Family

ID=6178958

Family Applications (1)

Application Number Title Priority Date Filing Date
ES527514A Expired ES8502337A1 (es) 1982-11-25 1983-11-24 Procedimiento para la obtencion de medios antimicoticos en forma de gel

Country Status (12)

Country Link
EP (1) EP0112485B1 (es)
JP (1) JPS59108712A (es)
KR (1) KR840006766A (es)
AT (1) ATE33759T1 (es)
CA (1) CA1209920A (es)
DE (2) DE3243546A1 (es)
DK (1) DK538683A (es)
ES (1) ES8502337A1 (es)
GR (1) GR79726B (es)
IL (1) IL70290A (es)
NO (1) NO834160L (es)
ZA (1) ZA838774B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4542020A (en) * 1984-08-17 1985-09-17 E. R. Squibb & Sons, Inc. Long-lasting adhesive antifungal suppositories
JPS61151117A (ja) * 1984-12-25 1986-07-09 Bayer Yakuhin Kk 抗真菌ゲル製剤
DE3614095A1 (de) * 1986-04-25 1987-10-29 Goedecke Ag Oxyalkylcellulose enthaltende gelzubereitung
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
JP2005097271A (ja) * 2003-08-20 2005-04-14 Matsumoto Shika Univ 抗真菌剤用組成物
US20050054583A1 (en) * 2003-08-20 2005-03-10 Matsumoto Dental University Composition for an antifungal agent for suppressing fungal growth in an oral cavity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL31756C (es) * 1962-04-26
US4056611A (en) * 1973-04-16 1977-11-01 Stiefel Laboratories, Inc. Therapeutic composition
US4313765A (en) * 1980-09-24 1982-02-02 Merck & Co., Inc. Synergistic blends of cellulase-free xanthan gum and cellulosics
DE3045915A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
JPS57120576A (en) * 1981-01-20 1982-07-27 Sumitomo Chem Co Ltd Novel imidazole ester
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
GR79726B (es) 1984-10-31
EP0112485A2 (de) 1984-07-04
EP0112485B1 (de) 1988-04-27
KR840006766A (ko) 1984-12-03
IL70290A (en) 1988-01-31
DE3243546A1 (de) 1984-05-30
JPS59108712A (ja) 1984-06-23
ZA838774B (en) 1984-07-25
CA1209920A (en) 1986-08-19
ES8502337A1 (es) 1985-01-01
NO834160L (no) 1984-05-28
DK538683A (da) 1984-05-26
EP0112485A3 (en) 1985-10-23
ATE33759T1 (de) 1988-05-15
IL70290A0 (en) 1984-02-29
DE3376386D1 (en) 1988-06-01
DK538683D0 (da) 1983-11-24

Similar Documents

Publication Publication Date Title
IL78175A0 (en) Azolylmethyloxiranes,their preparation and their use as crop protection agents
AU534447B2 (en) Hydroxyethyl-imidazoles and triazole derivatives and their use as antimycotic actents
SE8200171L (sv) 3-aminopropoxiaryl-derivat, framstellning derav och lekemedel innehallande dessa
AU8032682A (en) Formulations of known antimycotic azoles
AU536920B2 (en) Hydroxypropyl-triazole derivatives and their use as antimycotic agents
IT8348006A0 (it) Loro produzione derivati cefalosporinici e composizioni antibatteriche che li contengono, nonche' procedimento per la
IT8121849A0 (it) Procedimento per la preparazione di un agente anti-microbico, composizioni che lo contengono eloro uso nel trattamento di infezioni.
ES527514A0 (es) Procedimiento para la obtencion de medios antimicoticos en forma de gel
IL68945A0 (en) Bis-triazole derivatives,their preparation and pharmaceutical compositions containing them
IT8323022A0 (it) 2-sostituiti e relativo antibiotici di carbapenem derivati procedimento di preparazione.
IL99471A0 (en) Pharmaceutical compositions containing pyridylmethylsulphinyl-1h-benzimidazole derivatives as active ingredient therein
DE2961994D1 (en) Ethene-azole derivatives, process for their preparation, fungicidal compositions and process for their preparation, use of the azole derivatives in combating fungi and process for combating fungi
IT1171863B (it) Derivati del tiofene, loro preparazione e loro impiego come fungicidi
IL61989A (en) 1-(1,3,4-oxadiazolyl-phenoxy)-3-(phenylpiperazino)propan-2-ols and their derivatives,their preparation and pharmaceutical compositions containing them
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
IE810123L (en) N-(tetrazol-5-yl) retinamides
DK401783A (da) Herbicidt aktive 2-aryl-2-azolylmethyl-1,3-dioxepiner
IT8320920A0 (it) Derivati di cicloalcani, procedimento per la loro preparazione e composizioni che licontengono.
IT8109326A0 (it) Derivati del benzossazolone,procedimenti per la preparazione di questi e composizioni che li contengono
DK151082A (da) Fungicidt middel indeholdende triazolylderivater
IT8323010A0 (it) Derivati 15-cicloalifatici di 13,14-dideidro carboprostacicline eprocedimento per la loro preparazione.
ES511134A0 (es) "procedimiento de preparacion de nuevos derivados de la hidrazina, utiles como fungicidas y bactericidas".
ES508757A0 (es) "procedimiento para la preparacion de acidos antranilicos sustituidos con radicales basicos"
IT1170772B (it) Derivati pirazolidinonici dotati di proprieta' anoressiche, formulazioni farmaceutiche che li contengono e procedimento per la loro preparazione
SE8206217D0 (sv) N-substituerade ergolin- och 9,10-didehydro-ergolin-8-karboxamid- och -8-aminometyl-derivat, deras framstellning och farmaceutiska kompositioner derav